Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schonlein purpura
Aim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was...
Saved in:
Published in | Acta Paediatrica Vol. 99; no. 8; pp. 1248 - 1252 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2010
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch–Schonlein purpura (HSP), an acute type of systemic vasculitis in children.
Methods: We studied the activity of MMP‐2 and MMP‐9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi‐quantitative RT‐PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group.
Results: All 20 children with HSP showed increased levels of serum activity of MMP‐2 and MMP‐9 in acute phase as compared with their convalescent phase [MMP‐2 (p > 0.05); MMP‐9 (p > 0.05)] and their control counterparts [MMP‐2 (p < 0.001); MMP‐9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP‐2 (p < 0.05); MMP‐9 (p < 0.001)] and in their healthy controls [MMP‐2 (p < 0.001); MMP‐9 (p < 0.01)].
Conclusion: The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors. |
---|---|
AbstractList | Aim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch–Schonlein purpura (HSP), an acute type of systemic vasculitis in children.
Methods: We studied the activity of MMP‐2 and MMP‐9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi‐quantitative RT‐PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group.
Results: All 20 children with HSP showed increased levels of serum activity of MMP‐2 and MMP‐9 in acute phase as compared with their convalescent phase [MMP‐2 (p > 0.05); MMP‐9 (p > 0.05)] and their control counterparts [MMP‐2 (p < 0.001); MMP‐9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP‐2 (p < 0.05); MMP‐9 (p < 0.001)] and in their healthy controls [MMP‐2 (p < 0.001); MMP‐9 (p < 0.01)].
Conclusion: The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors. Abstract Aim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu’s arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch–Schonlein purpura (HSP), an acute type of systemic vasculitis in children. Methods: We studied the activity of MMP‐2 and MMP‐9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi‐quantitative RT‐PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group. Results: All 20 children with HSP showed increased levels of serum activity of MMP‐2 and MMP‐9 in acute phase as compared with their convalescent phase [MMP‐2 (p > 0.05); MMP‐9 (p > 0.05)] and their control counterparts [MMP‐2 (p < 0.001); MMP‐9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP‐2 (p < 0.05); MMP‐9 (p < 0.001)] and in their healthy controls [MMP‐2 (p < 0.001); MMP‐9 (p < 0.01)]. Conclusion: The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors. Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu's arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch-Schonlein purpura (HSP), an acute type of systemic vasculitis in children. We studied the activity of MMP-2 and MMP-9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi-quantitative RT-PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group. All 20 children with HSP showed increased levels of serum activity of MMP-2 and MMP-9 in acute phase as compared with their convalescent phase [MMP-2 (p > 0.05); MMP-9 (p > 0.05)] and their control counterparts [MMP-2 (p < 0.001); MMP-9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP-2 (p < 0.05); MMP-9 (p < 0.001)] and in their healthy controls [MMP-2 (p < 0.001); MMP-9 (p < 0.01)]. The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors. AbstractAim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu's arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch-Schonlein purpura (HSP), an acute type of systemic vasculitis in children.Methods: We studied the activity of MMP-2 and MMP-9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi-quantitative RT-PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group.Results: All 20 children with HSP showed increased levels of serum activity of MMP-2 and MMP-9 in acute phase as compared with their convalescent phase [MMP-2 (p > 0.05); MMP-9 (p > 0.05)] and their control counterparts [MMP-2 (p < 0.001); MMP-9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP-2 (p < 0.05); MMP-9 (p < 0.001)] and in their healthy controls [MMP-2 (p < 0.001); MMP-9 (p < 0.01)].Conclusion: The presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors. AIMAccelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological disorders and systemic vasculitides, especially Takayasu's arteritis and Kawasaki disease. Therefore, the aim of the present study was to investigate the potential role of MMPs in Henoch-Schonlein purpura (HSP), an acute type of systemic vasculitis in children.METHODSWe studied the activity of MMP-2 and MMP-9 in the sera using gelatin zymography and the transcriptional expression in peripheral blood mononuclear cells using semi-quantitative RT-PCR in 20 patients with HSP in acute and convalescent phase and in 20 healthy children, who were siblings of the subjects with same age group.RESULTSAll 20 children with HSP showed increased levels of serum activity of MMP-2 and MMP-9 in acute phase as compared with their convalescent phase [MMP-2 (p > 0.05); MMP-9 (p > 0.05)] and their control counterparts [MMP-2 (p < 0.001); MMP-9 (p < 0.001)]. Similarly, transcriptional expression of MMPs was found to be higher in the acute phase of HSP than in convalescent phase [MMP-2 (p < 0.05); MMP-9 (p < 0.001)] and in their healthy controls [MMP-2 (p < 0.001); MMP-9 (p < 0.01)].CONCLUSIONThe presence of excessive transcriptional expression and gelatinolytic activity of MMPs may be downstream to the actual aetiopathogenetic factors. |
Author | Bisht, D Minz, RW Dhawan, V Singh, S Mahajan, N |
Author_xml | – sequence: 1 givenname: N surname: Mahajan fullname: Mahajan, N organization: Department of Experimental Medicine and Biotechnology, Research Block 'B', Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India – sequence: 2 givenname: D surname: Bisht fullname: Bisht, D organization: Advanced Pediatric Center, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India – sequence: 3 givenname: V surname: Dhawan fullname: Dhawan, V organization: Department of Experimental Medicine and Biotechnology, Research Block 'B', Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India – sequence: 4 givenname: S surname: Singh fullname: Singh, S organization: Advanced Pediatric Center, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India – sequence: 5 givenname: RW surname: Minz fullname: Minz, RW organization: Department of Immunopathology, Research Block 'A', Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22946876$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20337780$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkVGPEyEQx4k54_VOv4Lhxfi0FZZlFx58qBftXdKoiaeX-EJYOutRWbYC9bbfXtbW-qiEhGH4_YfJ_C_QmR88IIQpmdO8Xm3mtOa0KMuymZckZwltBJ2Pj9Ds9HCGZkQQVvCSs3N0EeOGkJLJqn6CzkvCWNMIMkP-NmgfTbDbZAevHYZxGyDGfMHar_E3cDpZP7h9sgZrk-xPm_Z46HCvU7Aj7iFp54ZtGBJYryNEbD2-Bj-Y--KTuR-8y3m83YW89VP0uNMuwrPjeYk-v3t7e3VdrD4sb64Wq8JUtaBFJ9ZdBVS2FVtz4BXTQFsJjZS85kSYumO8lgKEaWlrpCZcGtowQlhFjaw0u0QvD3VzXz92EJPqbTTgnPYw7KJqqrpkXHD6b5IxLnNpkUlxIE0YYgzQqW2wvQ57RYmabFEbNU1fTdNXky3qty1qzNLnx092bQ_rk_CPDxl4cQR0NNp12RRj41-uzL6Jps7c6wP3YB3s_7sBtfi4mKKsLw56GxOMJ70O31XdsIaru_dL9aWqV3fLr29UxX4BzTu7MQ |
CitedBy_id | crossref_primary_10_1016_j_avsg_2016_02_011 crossref_primary_10_3109_0886022X_2012_757826 crossref_primary_10_1586_1744666X_2013_850028 crossref_primary_10_1007_s11010_017_2953_9 crossref_primary_10_1111_pde_12222 crossref_primary_10_1007_s13312_013_0020_5 crossref_primary_10_1155_2014_827105 |
Cites_doi | 10.1136/ard.2005.046300 10.1002/art.1780391019 10.1046/j.1365-2249.2001.01608.x 10.1046/j.1523-1755.2003.00939.x 10.1111/j.1745-7270.2008.00418.x 10.1016/j.bcp.2007.07.004 10.1007/s00467-003-1292-0 10.1080/03009740510026940 10.1016/j.ijcard.2009.09.557 10.1007/s00296-008-0800-8 10.1161/01.CIR.98.3.193 10.1016/B978-1-4160-0246-8.50029-2 10.1016/0003-2697(76)90527-3 10.1042/cs0810233 10.1002/jcla.20024 |
ContentType | Journal Article |
Copyright | 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Pædiatrica 2015 INIST-CNRS |
Copyright_xml | – notice: 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Pædiatrica – notice: 2015 INIST-CNRS |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7TM |
DOI | 10.1111/j.1651-2227.2010.01781.x |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Nucleic Acids Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Nucleic Acids Abstracts |
DatabaseTitleList | CrossRef MEDLINE Nucleic Acids Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1651-2227 |
EndPage | 1252 |
ExternalDocumentID | 10_1111_j_1651_2227_2010_01781_x 20337780 22946876 APA1781 ark_67375_WNG_V46LWGZB_4 |
Genre | article Journal Article |
GroupedDBID | .55 .GA .GJ 1OC 3O- 51W 51X 52N 52O 52P 52R 52T 52W 52X 53G 5GY 5HH 5LA 5RE 66C 7PT 930 A01 A03 AAWTL ABDBF ACGFS AI. ALMA_UNASSIGNED_HOLDINGS BSCLL BY8 EAD EAP EAS EBC EBD EBX EMB EMK EMOBN EPT ESX F5P LP6 LP7 N9D P4B P4D Q~Q SV3 TUS VH1 WQJ WRC WXI X7M ZGI .3N .Y3 05W 08R 0R~ 10A 1OB 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52S 52U 52V 5VS 702 8-0 8-1 8-3 8-4 8-5 8UM AAESR AAEVG AAHHS AANLZ AAONW AAQQT AASGY AAUGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIVO ABLJU ABPTK ABPVW ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGEJ ACGOF ACMXC ACPOU ACPRK ACSCC ACSMX ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXPE ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHEFC AHMBA AIACR AIURR AIWBW AJBDE AJWEG ALAGY ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBS EJD EX3 F00 F01 F04 FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HZ~ IQODW IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2W P2X P2Z PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WUP WVDHM WXSBR XG1 ZA5 ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7TM ABJNI ABQWH AFFPM AHBTC AITYG HGLYW HVGLF OIG |
ID | FETCH-LOGICAL-c4681-f8df4e19b43d5e543ae1b9e79956508c6f35698e8cb1bc9a059c17300341c94a3 |
IEDL.DBID | DR2 |
ISSN | 0803-5253 |
IngestDate | Sat Aug 17 01:13:47 EDT 2024 Fri Oct 25 09:42:43 EDT 2024 Fri Aug 23 02:01:10 EDT 2024 Sat Sep 28 08:01:29 EDT 2024 Sun Oct 22 16:06:41 EDT 2023 Sat Aug 24 00:55:27 EDT 2024 Wed Oct 30 09:59:57 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Pediatrics Matrix metalloprotienases Skin disease Transcription Enzyme Transcriptional expression Diseases of the osteoarticular system Cardiovascular disease Metalloendopeptidases Henoch-Schonlein purpura Gene expression Biological activity Vascular disease Peptidases Henoch-Schönlein purpura Hydrolases Capillary vessel disease Zymography |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4681-f8df4e19b43d5e543ae1b9e79956508c6f35698e8cb1bc9a059c17300341c94a3 |
Notes | ArticleID:APA1781 ark:/67375/WNG-V46LWGZB-4 istex:EA7F72BAE07785E02911FB9B1A46203EDA3485D4 These authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 20337780 |
PQID | 733597308 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_746235851 proquest_miscellaneous_733597308 crossref_primary_10_1111_j_1651_2227_2010_01781_x pubmed_primary_20337780 pascalfrancis_primary_22946876 wiley_primary_10_1111_j_1651_2227_2010_01781_x_APA1781 istex_primary_ark_67375_WNG_V46LWGZB_4 |
PublicationCentury | 2000 |
PublicationDate | August 2010 |
PublicationDateYYYYMMDD | 2010-08-01 |
PublicationDate_xml | – month: 08 year: 2010 text: August 2010 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Norway |
PublicationTitle | Acta Paediatrica |
PublicationTitleAlternate | Acta Paediatr |
PublicationYear | 2010 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | Bagga A, Kabra SK, Shrivastva RN, Bhuyan UN. Henoch-Schonlein Purpura in Northern Indian Children. Indian J Pediatr 1991; 28: 1153-7. Kumar L, Singh S, Goraya JS, Uppal B, Kakkar S, Walker R, et al. Henoch-Schonlein purpura: The Chandigarh Experience. Indian J Pediatr 1998; 35: 19-27. Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996; 39: 1747-53. Davies MJ. Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 1998; 98: 193-195. Zou CC, Zhao ZY, Tang LF, Liang L. Plasma levels of matrix metalloproteinase-9 in Henoch- Schönlein purpura. Scand J Rheumatol 2006; 35: 52-5. Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2004; 18: 206-10. Mahajan N, Dhawan V, Malik S, Jain S. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's Arteritis disease. Int J Cardiol 2009; doi: 10.1016/j.ijcard.2009.09.557. Ozen S, Ruperto N, Dillon MJ. EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936-41. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54. Nikkari ST, Hoyhtya M, Isola J, Nikkari T. Macrophages contain 92-KD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996; 149: 1427-33. Takeshita S, Tokutomi T, Kawasae H, Nakatani K, Tsujimoto H, Kamamura Y, et al. Elevated serum levels of matrix metalloproteinase-9 (MMP 9) in Kawasaki disease. Clin Exp Immunol 2001; 125: 340-4. Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, Meehan DT. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int 2003; 63: 1736-48. Vine N, Powell JT. Metalloproteinases in degenerative aortic disease. Clin Sci 1991; 816: 233-9. Guo Y, Peng X, Lei S. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin 2008; 40: 426-36. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 75: 346-59. Chua PK, Meish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 2003; 110: 308-14. Davin JC, Weening JJ. Diagnosis of Henoch-Schonlein purpura: renal or skin biopsy? Pediatr Nephrol 2003; 18: 1201-3. Mahajan N, Dhawan V. C-reactive protein (CRP) - induced up-regulation of MMPs and their tissue inhibitor in THP-1cells: Inhibitory effects of Atorvastatin. Mol Cell Biochem. doi: 10.1007/s11010-009-0340-x. Mahajan V, Singh S, Khullar M, Minz RW. Serum and urine nitric oxide levels in children with Henoch-Schonlein purpura during activity and remission: a study from North India. Rheumatol Int 2009; 29: 1069-72. 1991; 28 1996; 39 2004; 18 2006; 35 2006; 65 1976; 72 2009 1991; 816 2005 2004 2003; 18 2008; 75 2008; 40 1998; 98 2003; 63 2001; 125 2003; 110 2009; 29 1998; 35 1996; 149 e_1_2_7_3_2 Bagga A (e_1_2_7_5_2) 1991; 28 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 Kumar L (e_1_2_7_4_2) 1998; 35 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 Miller ML (e_1_2_7_2_2) 2004 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_11_2 e_1_2_7_22_2 e_1_2_7_21_2 e_1_2_7_20_2 Mahajan N (e_1_2_7_14_2) Nikkari ST (e_1_2_7_10_2) 1996; 149 Chua PK (e_1_2_7_9_2) 2003; 110 |
References_xml | – volume: 28 start-page: 1153 year: 1991 end-page: 7 article-title: Henoch–Schonlein Purpura in Northern Indian Children publication-title: Indian J Pediatr – volume: 65 start-page: 936 year: 2006 end-page: 41 article-title: EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides publication-title: Ann Rheum Dis – volume: 18 start-page: 206 year: 2004 end-page: 10 article-title: Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy publication-title: J Clin Lab Anal – year: 2009 article-title: Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu’s Arteritis disease publication-title: Int J Cardiol – article-title: C‐reactive protein (CRP) – induced up‐regulation of MMPs and their tissue inhibitor in THP‐1cells: Inhibitory effects of Atorvastatin publication-title: Mol Cell Biochem – volume: 40 start-page: 426 year: 2008 end-page: 36 article-title: How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes publication-title: Acta Biochim Biophys Sin – volume: 149 start-page: 1427 year: 1996 end-page: 33 article-title: Macrophages contain 92‐KD gelatinase (MMP‐9) at the site of degenerated internal elastic lamina in temporal arteritis publication-title: Am J Pathol – volume: 110 start-page: 308 year: 2003 end-page: 14 article-title: Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease publication-title: Clin Diagn Lab Immunol – volume: 29 start-page: 1069 year: 2009 end-page: 72 article-title: Serum and urine nitric oxide levels in children with Henoch–Schonlein purpura during activity and remission: a study from North India publication-title: Rheumatol Int – volume: 75 start-page: 346 year: 2008 end-page: 59 article-title: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease publication-title: Biochem Pharmacol – volume: 125 start-page: 340 year: 2001 end-page: 4 article-title: Elevated serum levels of matrix metalloproteinase‐9 (MMP 9) in Kawasaki disease publication-title: Clin Exp Immunol – volume: 35 start-page: 52 year: 2006 end-page: 5 article-title: Plasma levels of matrix metalloproteinase‐9 in Henoch‐ Schönlein purpura publication-title: Scand J Rheumatol – volume: 816 start-page: 233 year: 1991 end-page: 9 article-title: Metalloproteinases in degenerative aortic disease publication-title: Clin Sci – volume: 98 start-page: 193 year: 1998 end-page: 195 article-title: Aortic aneurysm formation: lessons from human studies and experimental models publication-title: Circulation – volume: 18 start-page: 1201 year: 2003 end-page: 3 article-title: Diagnosis of Henoch–Schonlein purpura: renal or skin biopsy? publication-title: Pediatr Nephrol – volume: 72 start-page: 248 year: 1976 end-page: 54 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding publication-title: Anal Biochem – start-page: 496 year: 2005 end-page: 511 – volume: 35 start-page: 19 year: 1998 end-page: 27 article-title: Henoch–Schonlein purpura: The Chandigarh Experience publication-title: Indian J Pediatr – start-page: 826 year: 2004 end-page: 30 – volume: 39 start-page: 1747 year: 1996 end-page: 53 article-title: Elevated levels of 92‐kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis publication-title: Arthritis Rheum – volume: 63 start-page: 1736 year: 2003 end-page: 48 article-title: Increased expression of MMP‐2, MMP‐9 (type IV collagenases/gelatinases), and MT1‐MMP in canine X‐linked Alport syndrome (XLAS) publication-title: Kidney Int – ident: e_1_2_7_12_2 doi: 10.1136/ard.2005.046300 – ident: e_1_2_7_7_2 doi: 10.1002/art.1780391019 – ident: e_1_2_7_8_2 doi: 10.1046/j.1365-2249.2001.01608.x – volume: 28 start-page: 1153 year: 1991 ident: e_1_2_7_5_2 article-title: Henoch–Schonlein Purpura in Northern Indian Children publication-title: Indian J Pediatr contributor: fullname: Bagga A – ident: e_1_2_7_19_2 doi: 10.1046/j.1523-1755.2003.00939.x – ident: e_1_2_7_22_2 doi: 10.1111/j.1745-7270.2008.00418.x – ident: e_1_2_7_6_2 doi: 10.1016/j.bcp.2007.07.004 – volume: 110 start-page: 308 year: 2003 ident: e_1_2_7_9_2 article-title: Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease publication-title: Clin Diagn Lab Immunol contributor: fullname: Chua PK – ident: e_1_2_7_16_2 doi: 10.1007/s00467-003-1292-0 – volume: 35 start-page: 19 year: 1998 ident: e_1_2_7_4_2 article-title: Henoch–Schonlein purpura: The Chandigarh Experience publication-title: Indian J Pediatr contributor: fullname: Kumar L – ident: e_1_2_7_14_2 article-title: C‐reactive protein (CRP) – induced up‐regulation of MMPs and their tissue inhibitor in THP‐1cells: Inhibitory effects of Atorvastatin publication-title: Mol Cell Biochem contributor: fullname: Mahajan N – ident: e_1_2_7_17_2 doi: 10.1080/03009740510026940 – volume: 149 start-page: 1427 year: 1996 ident: e_1_2_7_10_2 article-title: Macrophages contain 92‐KD gelatinase (MMP‐9) at the site of degenerated internal elastic lamina in temporal arteritis publication-title: Am J Pathol contributor: fullname: Nikkari ST – start-page: 826 volume-title: Nelson textbook of pediatrics year: 2004 ident: e_1_2_7_2_2 contributor: fullname: Miller ML – ident: e_1_2_7_11_2 doi: 10.1016/j.ijcard.2009.09.557 – ident: e_1_2_7_15_2 doi: 10.1007/s00296-008-0800-8 – ident: e_1_2_7_21_2 doi: 10.1161/01.CIR.98.3.193 – ident: e_1_2_7_3_2 doi: 10.1016/B978-1-4160-0246-8.50029-2 – ident: e_1_2_7_13_2 doi: 10.1016/0003-2697(76)90527-3 – ident: e_1_2_7_20_2 doi: 10.1042/cs0810233 – ident: e_1_2_7_18_2 doi: 10.1002/jcla.20024 |
SSID | ssj0023946 ssj0004374 |
Score | 2.014819 |
Snippet | Aim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several... Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several rheumatological... Abstract Aim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several... AIMAccelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several... AbstractAim: Accelerated extracellular matrix breakdown caused by the increased activity of matrix metalloproteinases (MMPs) has been implicated in several... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1248 |
SubjectTerms | Biological and medical sciences Case-Control Studies Child Child, Preschool Dermatology Female Gelatin - metabolism General aspects Henoch-Schonlein purpura Humans Male Matrix Metalloproteinase 2 - metabolism Matrix Metalloproteinase 9 - metabolism Matrix metalloprotienases Medical sciences Purpura, Schoenlein-Henoch - blood Purpura, Schoenlein-Henoch - enzymology Reverse Transcriptase Polymerase Chain Reaction Siblings Transcription, Genetic Transcriptional expression Vascular disorders of the skin Zymography |
Title | Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schonlein purpura |
URI | https://api.istex.fr/ark:/67375/WNG-V46LWGZB-4/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1651-2227.2010.01781.x https://www.ncbi.nlm.nih.gov/pubmed/20337780 https://search.proquest.com/docview/733597308 https://search.proquest.com/docview/746235851 |
Volume | 99 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA5SQXzxfhkvJQ_i2yyTyWWSx63aLmKLiLXFl5BkM7Vsm1n2Aluf_A_-Q3-JOZnZrSNFRHwbmEkgJ9_JOZl85wtCL2LEBp20Ivel4DkzzOWAm9wVyqlSVEwkMub-gRgdsrfH_LjjP0EtTKsPsfnhBp6R1mtwcGPnfScXnORQy9kxtEglyQDySUIrYHe9_nCpJMUopDndRoyqtoBHFjRuxDjtM3yu7LUXtq7DDKyARmnm0ZJ1ewXGVTlqP-VNMWv3NpqsR9tSVSaD5cIO3NffhCD_jznuoFtdaouHLRbvoms-3EM39rvD-_tomuLiepWKX_pVx8IN2IQxPkm8vNCcXcQOMBRcwL0WuKnxOdwjsMLnfgE0gSQtcRpi-J3j04BHPjTuy49v30FQNJzFN3ga0bOcmQfocPfNx1ejvLvwIXcREySv5bhmnijL6Jh7zqjxxCoPmnWQSDpRUy6U9NJZYp0yEWiOgOB-DMVOMUMfoq3QBP8YYeuZstbHya0ck4xaWVIjjTEVK7wqxhki6_nU01bXQ_-yH4qm1GBKDabUyZR6laGXaeI3DcxsAry4iuujgz39iYl3R3ufdzTL0HYPGZsGZRmRF-NPhvAaKjq6M5zRmOCb5VxXlMYtHi3kHz5hAuqbOcnQoxZll_0XlFaVLDIkElb-emh6-H4IT0_-teFTdLPlVQA18hnaWsyW_nlM1xZ2OzniT0w4L_w |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKwGX8oYUKD4gblnFsePYx-XRLrC7QqilFRfL9jpQdeus9iEtnPgP_EN-CR4nu2VRhRDiFimxpYy_yYzjb75B6GmI2KCTlqUu50XKNLMp4Ca1mbQy5yXjkYw5GPLeEXtzUpy07YCgFqbRh1j_cAPPiN9rcHD4Ib3p5bwgKRRzthQtUgrSCQnldvB-Cn0cXr6_0JJiFBKdditGZVPCIzIatmIF3eT4XDrtRuDahjVYApFSz4Itq6YJxmVZ6mbSG6PW_g00Xr1vQ1Y56yzmpmO__iYF-Z8MchPttNkt7jZwvIWuOH8bXR205_d30CSGxtWHKjzpli0R12PtR_hTpOb5evwlTICh5gJaW-C6wufQSmCJz90cmAJRXeLUhwg8w6ce95yv7ecf376Dpqgfhzt4EgC0mOq76Gj_1eGLXtr2fEhtgAVJKzGqmCPSMDoqXMGodsRIB7J1kEtaXtGCS-GENcRYqQPWLAHN_RCNrWSa3kNbvvbuAcLGMWmMC6tbWiYYNSKnWmitS5Y5mY0SRFYLqiaNtIf6ZUsUTKnAlApMqaIp1TJBz-LKrwfo6RlQ48pCHQ8P1AfG-8cHH58rlqC9DWisB-R5gF4IQQnCK6yo4NFwTKO9qxczVVIadnk0E394hHEocS5Igu43MLuYP6O0LEWWIB7B8tevprrvunC1-68Dn6BrvcNBX_VfD98-RNcbmgUwJR-hrfl04R6H7G1u9qJX_gQ0oTQU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQK1VseD_Co3iB2GUUjx3HXg6P6QDtqEKUVmws23GgmtYZzUMaWPEP_CFfgq-TmRJUIYTYjZTYUq7PzT2enHuM0NNQscEnLUtdn-cp08ymgJvUZtLKPi8Yj2LMgzEfHbE3J_lJq3-CXpjGH2LzhxtkRnxfQ4JPy6qb5DwnKfRytgotUgjSC3xym_FAhIEgvbuwkmIUeE67E6Oy6eARGQ07sZx2JT6XTtupW9uwBCvQUep5CGXVnIFxGUntct5YtIbX0WT9uI1WZdJbLkzPfv3NCfL_xOMGutZyWzxowHgTXXH-Fto5aL_e30bTWBjXr6lwp1u1MlyPtS_xpyjM8_XZlzABho4LONgC1xU-h4MEVvjcLUAnEL0lTn2ov3N86vHI-dp-_vHtOziK-rNwBU8DfJYzfQcdDV-9fzFK2xMfUhtAQdJKlBVzRBpGy9zljGpHjHRgWgdM0vKK5lwKJ6whxkodkGYJOO6HWmwl0_Qu2vK1d_cRNo5JY1xY3MIywagRfaqF1rpgmZNZmSCyXk81bYw91C8bohBKBaFUEEoVQ6lWCXoWF34zQM8mIIwrcnU83lMfGN8_3vv4XLEE7XaQsRnQ7wfkhQKUILyGigr5DB9ptHf1cq4KSsMej2biD7cwDg3OOUnQvQZlF_NnlBaFyBLEI1b--tHU4HAAvx7868AnaOfw5VDtvx6_fYiuNhoLkEk-QluL2dI9DtRtYXZjTv4EYwkyww |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptional+expression+and+gelatinolytic+activity+of+matrix+metalloproteinases+in+Henoch-Schonlein+purpura&rft.jtitle=Acta+p%C3%A6diatrica+%28Oslo%29&rft.au=MAHAJAN%2C+N&rft.au=BISHT%2C+D&rft.au=DHAWAN%2C+V&rft.au=SINGH%2C+S&rft.date=2010-08-01&rft.pub=Blackwell&rft.issn=0803-5253&rft.eissn=1651-2227&rft.volume=99&rft.issue=8&rft.spage=1248&rft.epage=1252&rft_id=info:doi/10.1111%2Fj.1651-2227.2010.01781.x&rft.externalDBID=n%2Fa&rft.externalDocID=22946876 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0803-5253&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0803-5253&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0803-5253&client=summon |